Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Exclusive: Biogen prices hemophilia drug on par with older therapies

 

Exclusive: Biogen prices hemophilia drug on par with older therapies

2014-04-18 21:08:28| Biotech - Topix.net

Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

Tags: par prices older drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

28.04 'Buying a first home is harder when you're single' 27.04 This Week in Agribusiness, April 27, 2024 27.04 Scentair Adds Patchouli to UK Home Fragrance Offerings 27.04 Weekly Recap: Heubach, BASF, PPG Top This Weeks Stories 27.04 Commentary: Committed to End Plastic Waste 26.04 Dead whistleblower accused Boeing of safety breaches 26.04 Introducing Mens Hybrid Skincare Brand Enhanse 26.04 Washington Corner April 2024 More »